News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lundbeck Inc. Embarks on Research Initiative to Identify and Develop Therapies that May Slow or Halt the Progression of Huntington's Disease


12/15/2010 9:38:25 AM

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck Inc. today launched a Huntington’s disease (HD) research initiative to identify and ultimately commercialize therapies that may slow or halt the progression of the disease. The research will be driven by collaborations with academic institutions and companies with promising compounds in development.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES